# Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery

> **NCT06414031** · PHASE3 · RECRUITING · sponsor: **Ulrich Ronellenfitsch, MD** · enrollment: 850 (estimated)

## Conditions studied

- Surgical Blood Loss
- Transfusion-dependent Anemia
- Abdomen Disease

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06414031
- **Lead sponsor:** Ulrich Ronellenfitsch, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-17
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 850 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06414031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06414031, "Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06414031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*